Evaluation of Silodosin and Pelvic Floor Muscle Training in Men With Benign Prostatic Hyperplasia and Overactive Bladder
NCT04681625 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172
Last updated 2023-12-07
Summary
This study will evaluate the efficacy of pelvic floor muscle training in men with benign prostatic hyperplasia and overactive bladder treated with Silodosin.
Conditions
- Benign Prostatic Hyperplasia (BPH)
- Overactive Bladder
Interventions
- BEHAVIORAL
-
Pelvic floor muscle training (PFMT) with suppressive urgency technique
Pelvic floor muscle training with suppressive urgency technique: 1. Education about proper urination training in the period without pathological urgency. 2. Education about conscious urgency suppression through PFMT - suppressive urgency technique. 3. Education on the principle and effect of PFMT. 4. Exercises of varying intensity of pelvic floor muscles in different positions. 5. Exercises to relax the pelvic floor muscles. Exercise 5 times a week for 20-30 minutes a day.
Sponsors & Collaborators
-
Comenius University
lead OTHER
Principal Investigators
-
Jan Svihra, Prof,MD,PhD · Department of Urology, Jessenius Faculty of Medicine, Comenius University Bratislava Slovak Republic
-
Magdalena Hagovska, Assoc.pr.PhD · Faculty of Medicine, PJ Safarik University, Kosice, Slovak Republic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-11
- Primary Completion
- 2022-06-30
- Completion
- 2022-09-30
Countries
- Slovakia
Study Locations
More Related Trials
-
Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP)
NCT00826527 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia
NCT02106182 ·Status: COMPLETED ·Phase: PHASE4
-
A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH
NCT00510406 ·Status: COMPLETED ·Phase: PHASE2
-
Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)
NCT01259531 ·Status: COMPLETED ·Phase: PHASE4
-
Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia
NCT00771394 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms
NCT01018511 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)
NCT04107896 ·Status: COMPLETED ·Phase: PHASE4
-
Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)
NCT01747577 ·Status: COMPLETED ·Phase: PHASE4
-
FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)
NCT02244294 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).
NCT02431754 ·Status: COMPLETED ·Phase: PHASE4
-
Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms
NCT01021332 ·Status: COMPLETED ·Phase: PHASE3
-
Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction
NCT00507455 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effect of Garcinia in Combination With Chromium on the Clinical Outcomes of Patients With LUTS/BPH
NCT04590534 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin
NCT02180997 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia
NCT02244242 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia
NCT00284518 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia
NCT02827578 ·Status: UNKNOWN ·Phase: PHASE3
-
The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months
NCT00224133 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH
NCT01260129 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy and Safety of Silodosin Singly or Combined With Ningmitai Capsules in the Treatment of Benign Prostatic Hyperplasia
NCT05551221 ·Status: RECRUITING ·Phase: PHASE4
-
Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms
NCT02244281 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms
NCT02252367 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB
NCT05494567 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Outcomes and Ejaculatory Function in BPO Patients Treated With Silodosin
NCT06989515 ·Status: NOT_YET_RECRUITING
-
Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia
NCT04103450 ·Status: COMPLETED ·Phase: PHASE3